Literature DB >> 20004782

Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis.

Emma Guttman-Yassky1, Mayte Suárez-Fariñas, Andrea Chiricozzi, Kristine E Nograles, Avner Shemer, Judilyn Fuentes-Duculan, Irma Cardinale, Peng Lin, Reuven Bergman, Anne M Bowcock, James G Krueger.   

Abstract

BACKGROUND: Psoriasis and atopic dermatitis (AD) are common, complex inflammatory skin diseases. Both diseases display immune infiltrates in lesions and epidermal growth/differentiation alterations associated with a defective skin barrier. An incomplete understanding of differences between these diseases makes it difficult to compare human disease pathology to animal disease models.
OBJECTIVE: To characterize differences between these diseases in expression of genes related to epidermal growth/differentiation and inflammatory circuits.
METHODS: We performed genomic profiling of mRNA in chronic psoriasis (n = 15) and AD (n = 18) skin lesions compared with normal human skin (n = 15).
RESULTS: As expected, clear disease classifications could be constructed on the basis of expected immune polarity (T(H)1, T(H)2, T(H)17) differences. However, even more striking differences were identified in epidermal differentiation programs that could be used for precise disease classifications. Although both psoriasis and AD skin lesions displayed regenerative epidermal hyperplasia, which is a general alteration in epidermal growth, keratinocyte terminal differentiation was differentially polarized. In AD, we found selective defects in expression of multiple genes encoding the cornified envelope, with the largest alteration in loricrin (expressed at 2% of the level of normal skin). At the ultrastructural level, the cornified envelope in AD was broadly defective with highly decreased compaction of corneocytes and reduced intercellular lipids. Hence, the entire keratinocyte terminal differentiation program (cytoplasmic compaction, cornification, and lipid release) is defective in AD, potentially underlying the immune differences.
CONCLUSION: Our study shows that although alterations in barrier responses exist in both diseases, epidermal differentiation is differentially polarized, with major implications for primary disease pathogenesis.

Entities:  

Mesh:

Year:  2009        PMID: 20004782     DOI: 10.1016/j.jaci.2009.09.031

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  88 in total

1.  Gene transcription abnormalities in canine atopic dermatitis and related human eosinophilic allergic diseases.

Authors:  Douglas A Plager; Sheila M F Torres; Sandra N Koch; Hirohito Kita
Journal:  Vet Immunol Immunopathol       Date:  2012-06-12       Impact factor: 2.046

2.  Enhancement of keratinocyte differentiation by rose absolute oil.

Authors:  Jin-Hwa Kim; Dae-Kyoung Choi; Sang-Sin Lee; Sun Ja Choi; Chang Deok Kim; Tae-Jin Yoon; Jeung-Hoon Lee
Journal:  Ann Dermatol       Date:  2010-08-05       Impact factor: 1.444

3.  2,3,7,8-Tetrachlorodibenzo-p-dioxin increases the expression of genes in the human epidermal differentiation complex and accelerates epidermal barrier formation.

Authors:  Carrie Hayes Sutter; Sridevi Bodreddigari; Christina Campion; Ryan S Wible; Thomas R Sutter
Journal:  Toxicol Sci       Date:  2011-08-11       Impact factor: 4.849

4.  Ichthyosis molecular fingerprinting shows profound TH17 skewing and a unique barrier genomic signature.

Authors:  Kunal Malik; Helen He; Thy Nhat Huynh; Gary Tran; Kelly Mueller; Kristina Doytcheva; Yael Renert-Yuval; Tali Czarnowicki; Shai Magidi; Margaret Chou; Yeriel D Estrada; Huei-Chi Wen; Xiangyu Peng; Hui Xu; Xiuzhong Zheng; James G Krueger; Amy S Paller; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2018-05-24       Impact factor: 10.793

5.  Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection.

Authors:  Hitokazu Esaki; David A Ewald; Benjamin Ungar; Mariya Rozenblit; Xiuzhong Zheng; Hui Xu; Yeriel D Estrada; Xiangyu Peng; Hiroshi Mitsui; Thomas Litman; Mayte Suárez-Fariñas; James G Krueger; Emma Guttman-Yassky
Journal:  J Allergy Clin Immunol       Date:  2015-01       Impact factor: 10.793

6.  Skin barrier defects in atopic dermatitis.

Authors:  Rachana Agrawal; Judith A Woodfolk
Journal:  Curr Allergy Asthma Rep       Date:  2014-05       Impact factor: 4.806

7.  A specific molecular signature for psoriasis and eczema.

Authors:  Susana Coimbra; Alice Santos-Silva
Journal:  Ann Transl Med       Date:  2015-04

8.  Epidermal ablation of Dlx3 is linked to IL-17-associated skin inflammation.

Authors:  Joonsung Hwang; Ryosuke Kita; Hyouk-Soo Kwon; Eung Ho Choi; Seung Hun Lee; Mark C Udey; Maria I Morasso
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

Review 9.  [Personalized medicine in the field of inflammatory skin diseases].

Authors:  N Garzorz-Stark; K Eyerich
Journal:  Hautarzt       Date:  2019-01       Impact factor: 0.751

Review 10.  Post-genomics and skin inflammation.

Authors:  Daniela Braconi; Giulia Bernardini; Annalisa Santucci
Journal:  Mediators Inflamm       Date:  2010-09-19       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.